169 related articles for article (PubMed ID: 38612577)
1. Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer.
Feng C; Li N; Gao G; He Q; Kwok LY; Zhang H
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612577
[TBL] [Abstract][Full Text] [Related]
2. The impact of MIF deficiency on alterations of fecal microbiota in C57BL/6 mice induced by Trichinella spiralis infection.
Xie Y; Xu D; Yan S; Hu X; Chen S; Guo K; Wang J; Chen Q; Guan W
FASEB J; 2023 Oct; 37(10):e23202. PubMed ID: 37732633
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antibiotics associated gut microbiome disturbance impairs T cell immunity and promotes lung cancer metastasis: a retrospective study.
Xu K; Cai J; Xing J; Li X; Wu B; Zhu Z; Zhang Z
BMC Cancer; 2022 Nov; 22(1):1182. PubMed ID: 36384523
[TBL] [Abstract][Full Text] [Related]
5. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
[TBL] [Abstract][Full Text] [Related]
6. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
7. Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity.
Hu X; Yu C; He Y; Zhu S; Wang S; Xu Z; You S; Jiao Y; Liu SL; Bao H
BMC Microbiol; 2024 Apr; 24(1):119. PubMed ID: 38580930
[TBL] [Abstract][Full Text] [Related]
8. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.
Bulow C; Langdon A; Hink T; Wallace M; Reske KA; Patel S; Sun X; Seiler S; Jones S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
mSphere; 2018 Nov; 3(6):. PubMed ID: 30463925
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells.
Alrafas HR; Busbee PB; Nagarkatti M; Nagarkatti PS
J Leukoc Biol; 2019 Aug; 106(2):467-480. PubMed ID: 30897248
[TBL] [Abstract][Full Text] [Related]
10. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
[TBL] [Abstract][Full Text] [Related]
11. Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer.
Luo WC; Mei SQ; Huang ZJ; Chen ZH; Zhang YC; Yang MY; Liu JQ; Xu JY; Yang XR; Zhong RW; Tang LB; Yin LX; Deng Y; Peng YL; Lu C; Chen BL; Ke DX; Tu HY; Yang JJ; Xu CR; Wu YL; Zhou Q
J Transl Med; 2024 Apr; 22(1):326. PubMed ID: 38566102
[TBL] [Abstract][Full Text] [Related]
12. Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota.
Gill T; Stauffer P; Asquith M; Laderas T; Martin TM; Davin S; Schleisman M; Ramirez C; Ogle K; Lindquist I; Nguyen J; Planck SR; Shaut C; Diamond S; Rosenbaum JT; Karstens L
Front Immunol; 2022; 13():965634. PubMed ID: 36248884
[TBL] [Abstract][Full Text] [Related]
13. Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.
Vernocchi P; Gili T; Conte F; Del Chierico F; Conta G; Miccheli A; Botticelli A; Paci P; Caldarelli G; Nuti M; Marchetti P; Putignani L
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227982
[TBL] [Abstract][Full Text] [Related]
14. Taxonomic and metabolic development of the human gut microbiome across life stages: a worldwide metagenomic investigation.
Mancabelli L; Milani C; De Biase R; Bocchio F; Fontana F; Lugli GA; Alessandri G; Tarracchini C; Viappiani A; De Conto F; Nouvenne A; Ticinesi A; Bussolati O; Meschi T; Cecchi R; Turroni F; Ventura M
mSystems; 2024 Apr; 9(4):e0129423. PubMed ID: 38441032
[TBL] [Abstract][Full Text] [Related]
15. A metagenomic study of the gut microbiome in Behcet's disease.
Ye Z; Zhang N; Wu C; Zhang X; Wang Q; Huang X; Du L; Cao Q; Tang J; Zhou C; Hou S; He Y; Xu Q; Xiong X; Kijlstra A; Qin N; Yang P
Microbiome; 2018 Aug; 6(1):135. PubMed ID: 30077182
[TBL] [Abstract][Full Text] [Related]
16. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
17. Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the "lung and large intestine stand in exterior-interior relationship" theory.
Li L; Zhong H; Wang Y; Pan Z; Xu S; Li S; Zeng G; Zhang W; Li J; He L
Front Cell Infect Microbiol; 2024; 14():1341032. PubMed ID: 38415012
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets.
Jiang H; Zeng W; Zhang X; Li Y; Wang Y; Peng A; Cao D
Front Cell Infect Microbiol; 2023; 13():1211855. PubMed ID: 38304459
[TBL] [Abstract][Full Text] [Related]
19. [Association between Immunotherapy with Immune Checkpoint Inhibitors(Anti-PD-1 Antibodies)and Intestinal Microbiota].
Ozaki Y; Suzuki Y; Nishiyama K; Suzutani T; Suzuki H
Gan To Kagaku Ryoho; 2021 Sep; 48(9):1096-1099. PubMed ID: 34521783
[TBL] [Abstract][Full Text] [Related]
20. [Buzhong Yiqi Decoction ameliorates spleen deficiency syndrome by regulating gut microbiota].
Yu HC; Meng YY; Wang EK; Yuan JY; Peng Y; Li XB
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1028-1043. PubMed ID: 38621910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
